Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myobloc for Upper Extremity Hypertonia in Children
NCT00238641Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jan 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type b in cerebral palsy (CP), sponsored by Stanford University. Started Jan 2002; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT00238641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238641.